Novavax, INC.
Biotechnology
Based in MD
🤖
AI Overview
With $440K in lobbying spend across 20 quarterly filings, Novavax, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2025.
$440K
Total Spend
5
Years Active
1
Firms Hired
5
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $70K |
| 2022 | $130K |
| 2023 | $60K |
| 2024 | $80K |
| 2025 | $100K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Novavax, INC. disclosed contacting in their lobbying filings.
State, Dept of (DOS)HOUSE OF REPRESENTATIVESSENATEWhite House Office
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to vaccine policy
COVID-19 vaccine and pandemic-related issues
Vaccine policy
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
United Assn of Journeymen & Apprentices of the Plumbing & Pipefitting Industry
$5.7M total spend
Plasma Protein Therapeutics Association
$4.8M total spend
Redwood Holdings, LLC FKA Redwood Capital Investments
$2.7M total spend
The United States Pharmacopeial Convention
$2.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.